Endocrine University®: Disease Management & Technology Skills for Endocrinology Fellows in Training

March 2, 2019 to March 7, 2019

The field of clinical endocrinology is extremely diverse considering the multiple disease states endocrinologists must diagnose and manage on a daily basis (e.g., diabetes, thyroid, osteoporosis, lipids, reproduction, pituitary, obesity, hypertension, etc.).  Endocrinology fellows -in-training and their endocrine training program directors have recognized a growing need to significantly enhance the endocrine curriculum, particularly in those areas where new technology has become essential to the practice of endocrinology. Regrettably, the majority of the endocrine training programs lack the resources necessary to provide adequate education in these areas. This deficiency is apparent by virtue of the overwhelming response by AACE members who have registered for existing accreditation/certification courses provided by AACE and ACE since 1995, and by our endocrinology fellow members who have indicated a need for a comprehensive course that fills this educational void.

Target Audience

This program is specifically designed for Final Year Endocrine Fellows in Training.

Learning Objectives

  • Provide final year endocrinology fellows with training in areas where new technology has become essential to the practice of endocrinology.
  • Further educate fellows in Bone Mass Measurement with the eventual option for obtaining certification.  Further educate fellows utilizing hands on training in the areas of Thyroid Ultrasound / FNA Biopsy and Insulin Pump Therapy.
  • Provide a comprehensive course to endocrinology fellows that will address educational areas, which are not adequately covered in their respective training programs.
Additional information
Available for MOC Points?: 
No
Practice Area: 
Adrenal
Diabetes
Hypertension
Hypoglycemia
Lipids
Nutrition
Obesity
Parathyroid & Bone
Thyroid
UGFNA
Course summary
Available credit: 
  • 43.50 AMA
  • 43.50 Attendance
Course opens: 
02/28/2019
Course expires: 
12/31/2019
Event starts: 
03/02/2019 - 7:00am
Event ends: 
03/07/2019 - 11:30am
Cost:
$0.00

Endocrine University®

Disease Management & Technology Skills for Endocrinology Fellows in Training

Kahler Grand Hotel - Rochester, MN

March 2-7, 2019

COURSE ROOM LOCATION

Marriott Ballroom, 2nd Floor = (MB)Marriott Ballroom Foyer, 2nd Floor = (MBF)
Heritage Ballroom, Kahler Hotel, Subway Level = (HB)Heritage Ballroom Foyer, Kahler Hotel, Subway Level = (HBF)
Windsor Ballroom, Kahler Hotel, Subway Level = (WB) 

REGISTRATION - FRIDAY, March 1, 2019

5:00-7:00pm.    Early Registration (HBF)

PROGRAM - SATURDAY, MARCH 2, 2019

Endocrine Neck Sonography Module

Moderator:  Dev Abraham, MD, MRCP, FACE, ECNU

Schedule and Sessions
Time
Event
Supporting Files
6:00-6:45 a.m.  Registration, Breakfast and Exhibits (HBF) 
6:45-7:00 a.m. Welcome and Announcements 
7:00-7:45 a.mAnatomy and Thyroid Pathology (HB) Diana Dean, MD, FACE  
7:45-8:30 a.m. Ultrasound Physics and Doppler (HB) Robert A. Levine, MD, FACE, ECNU VIEW PRESENTATION
8:30-9:15 a.m.Ultrasound Evaluation of Thyroid Nodules (HB) Mark Lupo, MD, FACE, ECNUVIEW PRESENTATION
9:15-9:35 a.m.Break and Exhibits (HBF) 
9:35-10:20 a.m.Lymphnode Mapping and Surveillance (HB) Mira Milas MD, FACSVIEW PRESENTATION
10:20-11:05am

US-Guided FNA of Nodules and Lymph Nodes (HB) Debra Margulies, MD, FACE, ECNU

  1.  Review suggested guidelines on when to perform FNA on a thyroid nodule
  2. Demonstrate the use of perpendicular and parallel needle approaches into a thyroid nodule or lymph node
  3. Discuss practical tips for successful FNA and slide making
VIEW PRESENTATION
11:05-11:50 am

Parathyroid Ultrasound (HB) Dev Abraham, MD, MRCP, FACE, ECNU 

  1. Recognize the ultrasound appearances and features of parathyroid adenomas.
  2. Understand the anatomical variations in the location of parathyroid glands.
  3. Define the role of US guided FNA biopsies with PTH estimation in syringe aspirate in the localization of parathyroid adenomas.
  4. Clinical and US findings seen in parathyroid carcinoma and atypical adenomas.
VIEW PRESENTATION
12:00-1:30 pm

Lunch (MB) - (no CME for this session)

Welcoming Remarks Hossein Gharib, MD, MACP, MACE, Dean, Endocrine University®

Daniel L. Hurley, MD, FACE, President, AACE

Robert Wermers, MD, FACE, Chair, Mayo Division of Endocrinology and Metabolism

J. Woody Sistrunk, MD, FACE, ECNU “Of Mice, Men, Women and AACE: A Personal and Professional Journey through the Past 25 Years of AACE”

Thom W. Rooke, MD, FSVM, “Quest for Cortisone”

VIEW PRESENTATION
1:45-3:45 pm

Lab Group 1 (WB)

Dev Abraham, MD, MRCP, ECNU

Diana Dean, MD, FACE

Robert A Levine, MD, FACE, ECNU  

Mark A. Lupo, MD, FACE, ECNU 

Debra Margulies, MD, FACE, ECNU

J. Woody Sistrunk, MD, FACE, ECNU

Mira Milas MD, FACS

Dawn Boynton, RDMS, RVT

Jana Hansen, RDMS, RVT

Jackie Kaddatz, BS, RDMS

Crystal Koski, RDMS, RVT

Kevin Rooker, RT(R), RDMS, RVT

Kate Ryan, RDMS, RVT

Emily Smith, BS, RDMS, RVT

Michelle Waletzko, RDMS, RVT

Sara Willaert, RDMS

Joel Wolery, RDMS

  1. Perform a proper neck ultrasound exam according to standardized AIUM/AACE protocol
  2. Address proper mechanics of ultrasound imaging techniques
  3. Correlate ultrasound physics principles with sonographic image creation
  4. Recognize normal anatomic architecture of the neck from suspected pathologic structures.
 
1:45-3:45 pm  Concurrent Lectures for Group 2 (HB) 
1:45-2:45 pm

Thyroid Cancer - What You Need to Know (HB) Mimi Hu, MD 

1. Review the differences between various types of thyroid cancer

2. Understand the evaluation and management strategies for thyroid cancer

3. Review the available treatment options for advanced thyroid cancer

VIEW PRESENTATION
2:45-3:45 pm

Cytology Workshop (HB) R. Mack Harrell, MD, FACP, FACE, ECNU and Michael Rivera, MD  

  1. Delineate the cytological features of the new Bethesda classification and their clinical implications
  2. Discuss how thyroid US findings influence the decision for FNA and the eventual interpretation of FNA cytological and molecular tests
  3. Outline the appropriate steps for smear preparation, staining and on side adequacy evaluation
  4. Lay out a plan for US, FNA and cytology process improvement in the care of thyroid nodule patients  
 
3:45 – 4:15 pmBreak and Exhibits (HBF) 
4:15-6:15 pm 

Lab Group 2 (WB)

Dev Abraham, MD, MRCP, ECNU

Diana Dean, MD, FACE

Robert A Levine, MD, FACE, ECNU  

Mark A. Lupo, MD, FACE, ECNU 

Debra Margulies, MD, FACE, ECNU

Mira Milas MD, FACS

J. Woody Sistrunk, MD, FACE, ECNU

Dawn Boynton, RDMS, RVT

Jana Hansen, RDMS, RVT

Jackie Kaddatz, BS, RDMS

Crystal Koski, RDMS, RVT

Kevin Rooker, RT(R), RDMS, RVT

Kate Ryan, RDMS, RVT

Emily Smith, BS, RDMS, RVT

Michelle Waletzko, RDMS, RVT

Sara Willaert, RDMS

Joel Wolery, RDMS

  1.  Perform a proper neck ultrasound exam according to standardized AIUM/AACE protocol
  2. Address proper mechanics of ultrasound imaging techniques
  3. Correlate ultrasound physics principles with sonographic image creation
  4. Recognize normal anatomic architecture of the neck from suspected pathologic structures.
 
4:15-6:15 pmConcurrent Lectures for Group 1 (HB) 
4:15-5:15 pm

Thyroid Cancer - What You Need to Know (HB) Mimi Hu, MD

1. Review the differences between various types of thyroid cancer

2. Understand the evaluation and management strategies for thyroid cancer

3. Review the available treatment options for advanced thyroid cancer

 
5:15-6:15 pm  

Cytology Workshop (HB) R. Mack Harrell, MD, FACP, FACE, ECNU and Michael Rivera, MD                                                             

  1. Delineate the cytological features of the new Bethesda classification and their clinical implications
  2. Discuss how thyroid US findings influence the decision for FNA and the eventual interpretation of FNA cytological and molecular tests
  3. Outline the appropriate steps for smear preparation, staining and on side adequacy evaluation
  4. Lay out a plan for US, FNA and cytology process improvement in the care of thyroid nodule patients           
VIEW PRESENTATION
6:15 pm Adjourn 
7:15-9:15 pmReception with Mayo Clinic Department of Endocrinology (Mathews Lobby – Mayo Building) 
8:00 p.m.  Endocrine University® Class of 2019 Picture (Grand Staircase in Landow Atrium/Gonda) 

PROGRAM - SUNDAY, March 3, 2019

Endocrine Neck Sonography Module (Continued)

Moderator:  Mark A Lupo, MD, FACE, ECNU

Schedule and Sessions
Time
Event
Supporting Files
6:30-7:00 a.m. 

Breakfast and Exhibits (HBF)

 
7:00-7:40 a.m.

Coding and Report Writing (HB) J. Woody Sistrunk, MD, FACE, ECNU

  1. Discuss essentials of US and US-FNA coding
  2. Review what needs to be included in an US report
  3. Highlight endocrinologist-performed US  and ECNU standards in quality reporting
VIEW PRESENTATION
7:40–8:40 a.m. 

Case Presentation and Panel Discussion on Neck Imaging Findings (HB)

Panel:  Mark A. Lupo, MD, FACE, ECNU, J. Woody Sistrunk, MD, FACE, ECNU; Mack Harrell, MD, FACE, ECNU

Case Presenters:  Robert A Levine, MD, FACE, ECNU; Debbie Margulies, MD, FACE, ECNU, Mira Millas MD, FACS,                                                               

  1. Demonstrate the application of point of contact ultrasound in the evaluation of patients with thyroiditis, nodules, cancer and PHPT
  2. Discuss the process of on-the-spot decision making regarding biopsy and follow up surveillance

VIEW PRESENTATION

VIEW PRESENTATION

8:40–9:40 a.m.  

Audience Participation in Neck Ultrasound Imaging – ARS (HB)

Cases:  Dev Abraham, MD, MRCP, ECNU, Mark A. Lupo, MD, FACE, ECNU, J. Woody Sistrunk, MD, FACE, ECNU                                                  

  1. Pattern recognition of thyroid and parathyroid tumors in the neck
  2. Active audience participation in decisions regarding when to biopsy and when to use follow up.
  3. Explanation provided by presenter for decision making.

Note: This session does not have panel discussants.

 
9:40-10:00 a.m. 

Break and Exhibits HBF)

 
10:00-11:00 a.m.

FNA Lab Group 1 (WB)

Dev Abraham, MD, MRCP, ECNU

Diana Dean, MD, FACE                 

R. Mack Harrell, MD, FACE, ECNU

Robert A Levine, MD, FACE, ECNU  

Mark A. Lupo, MD, FACE, ECNU 

Debra Margulies, MD, FACE, ECNU

Mira Milas MD, FACS

J. Woody Sistrunk, MD, FACE, ECNU

Dawn Boynton, RDMS, RVT

Jana Hansen, RDMS, RVT

Jackie Kaddatz, BS, RDMS

Crystal Koski, RDMS, RVT

Kevin Rooker, RT(R), RDMS, RVT

Kate Ryan, RDMS, RVT

Emily Smith, BS, RDMS, RVT

Michelle Waletzko, RDMS, RVT

Sara Willaert, RDMS

Joel Wolery, RDMS                       

  1.  Learn how to properly prepare the probe for biopsy (clean vs. sterile technique).
  2. Understand the spatial relationship of needle to probe in the performance of an Ultrasound-guided FNA biopsy in both the parallel and perpendicular approaches
  3. Practice both the parallel and perpendicular approaches toward developing proficiency.
 
10:00-11:00 a.m. 

Concurrent Lecture for Group 2 (HB)

Graves Ophthalmopathy Evaluation and Management for the Endocrinologist (HB) James Garrity, MD

1.  Discuss the office evaluation of GO

2.  Review treatment of Graves’ disease in GO patients

3.  Review treatment of GO and GO complications

VIEW PRESENTATION
11:00-11:15 a.m. Break and Exhibits (HBF) 
11:15 – 12:15

FNA Lab Group 2 (WB)

Dev Abraham, MD, MRCP, ECNU

Diana Dean, MD, FACE

R. Mack Harrell, MD, FACE, ECNU

Robert A Levine, MD, FACE, ECNU  

Mark A. Lupo, MD, FACE, ECNU 

Debra Margulies, MD, FACE, ECNU

Mira Milas MD, FACS

J. Woody Sistrunk, MD, FACE, ECNU

Dawn Boynton, RDMS, RVT

Jana Hansen, RDMS, RVT

Jackie Kaddatz, BS, RDMS

Crystal Koski, RDMS, RVT

Kevin Rooker, RT(R), RDMS, RVT

Kate Ryan, RDMS, RVT

Emily Smith, BS, RDMS, RVT

Michelle Waletzko, RDMS, RVT

Sara Willaert, RDMS  

Joel Wolery, RDMS

  1.  Learn how to properly prepare the probe for biopsy (clean vs. sterile technique).
  2. Understand the spatial relationship of needle to probe in the performance of an Ultrasound-guided FNA biopsy in both the parallel and perpendicular approaches
  3. Practice both the parallel and perpendicular approaches toward developing proficiency.
 
11:15am-12:15pm   

Concurrent Lecture for Group 1 (HB)

Graves Ophthalmopathy Evaluation and Management for the Endocrinologist (HB) James Garrity, MD

1.  Discuss the office evaluation of GO

2.  Review treatment of Graves’ disease in GO patients

3.  Review treatment of GO and GO complications

 
12:30-2:00 pm 

Cushing Syndrome (MB) 

William F. Young, Jr., MD, MSc, FACE, FACP

  1. Review the diagnostic approach to the patient with possible Cushing syndrome
  2. Describe the levels of diagnostic testing in evaluating a patient with Cushing syndrome
  3. Demonstrate the role for clinical and biochemical phenotypes in directing case-detection, subtype evaluation, and treatment for Cushing syndrome
VIEW PRESENTATION
2:15-3:15pm  

H. Jack Baskin Lecture (HB)

Hossein Gharib, MD, MACP, MACE

Thyroid Case Studies using ARS

1.  Evaluate and follow a patient with benign nodule      

2.  Test and Management of a patient with cytology showing follicular neoplasm 

3.  Papillary Thyroid Carcinoma:  Incidence, Diagnosis, Surgery and Follow Up

VIEW PRESENTATION
3:15-3:45 pm   Coffee Break (HBF) 
3:45-4:45 pm 

Pituitary Imaging for the Endocrinologist (HB)

William Young, MD, MSc, FACP, FACE

  1.  Review sellar mass imaging phenotypes
  2. Correlate pituitary imaging phenotypes with clinical findings
  3. Apply pituitary imaging findings to case management
VIEW PRESENTATION
4:45-:45 pm 

Growth Hormone replacement: Not just for kids! (HB)

Susan Samson, MD PhD FRCPC FACE

                                       

  1. Describe the causes, symptoms and clinical consequences of growth hormone deficiency in adult patients
  2. Identify the appropriate dynamic testing for the diagnosis of growth hormone deficiency in adults or patients transitioning from adolescence to adulthood.
  3. Integrate the current evidence of the risks and benefits of growth hormone therapy with patient specific characteristics to decide on initiation of growth hormone therapy
VIEW PRESENTATION
5:45 pm   Sessions adjourn 
6:30-8:30 pm

Dinner – Pizza Buffet and Roundtables (MB) (no CME for this session)

Kurt A. Kennel, MD (Nutrition); Caroline Davidge-Pitts, MD (Male Hypogonadism); Karen B. Grothe, PhD, LP;   Meera Shah, MD,ChB and Travis McKenzie, MD (Bariatric Surgery Cases); Bart Clarke, MD (Parathyroid –hypo/hyper); Adrian Vella, MD and Geoff Thompson, MD (Insulinoma); John Morris, MD and Melanie Lyden, MD (Thyroid Cancer); Irina Bancos, MD (Adrenal Tumors); Yogish C. Kudva, M.B.B.S. (Diabetes Technology and CGMs); Chris Guerin, MD (Lipidology for the Endocrinologist)

 

PROGRAM - MONDAY, March 4, 2019

Diabetes / Diabetes Technology Module

Moderator:   George Grunberger, MD

Schedule and Sessions
Time
Event
Supporting Files
7:00-7:50 a.m. Breakfast and Exhibits (HBF) 
7:50-8:20 a.m. 

Hypoglycemia: Still the Limiting Factor in Glycemic Management of Diabetes (HB) Dace L. Trence, MD, FACE

  1. Awareness if the ramifications of hypoglycemia- acute and chronic
  2. Recognize the changing definitions of hypoglycemia
  3. Review prevention and management of hypoglycemia
VIEW PRESENTATION
8:25-8:55 a.m.

Should The Results of Cardiovascular Outcome Trials Change the  Way We Treat Type 2 diabetes? (HB) Richard Pratley, MD                                        

  1. Compare and contrast the results of recent cardiovascular outcomes studies in patients with diabetes mellitus.
  2. Assess new recommendations for managing patients with diabetes mellitus at heightened risk of cardiovascular disease
  3. Discuss how to incorporate new information on the effects of diabetes drugs on CV risk into your practice
VIEW PRESENTATION
9:00-9:30 a.m.

Specific Types of Diabetes Mellitus due to Other Causes: What’s the  Latest? (HB) George Grunberger, MD, FACP, FACE

  1. update on classification of diabetes mellitus
  2. explain etiology and diagnosis of specific subtypes of diabetes mellitus
  3. consider therapeutic approaches to specific diabetes subtypes
VIEW PRESENTATION
9:35-10:20 a.m.  

Current Status of Insulin Pump and Continuous Glucose Monitoring (HB) Bruce W. Bode, MD, FACE

                                                             

1.      Be aware of the current insulin pumps and CGM devices on the market

2.      Be able to list the indications for CGM devices

3.      Be able to list the indications for insulin pumps

VIEW PRESENTATION
10:20-10:45 a.m.   Coffee Break (HBF) 
10:45-11:30 a.m. 

Case Studies:  Interpreting Pump and CGM Downloads (HB) Irl Hirsch, MD

1.  Review both basic and advanced understanding of statistical interpretation of blood glucose data

2.  Interpret pump downloads with special emphasis on appreciation of use of bolus calculator over-rides

3.  Interpret simple and unusual downloads of both major CGM devices used in the US in 2019

VIEW PRESENTATION
11:30 a.m.-12:00 p.m.  

Future of Diabetes Technology: Towards the Bionic Pancreas (HB) George Grunberger, MD, FACP, FACE

  1. Be aware of advances in insulin delivery and glucose monitoring
  2. Recognize the technological challenges with the “artificial pancreas”: glucose sensing, insulin delivery, and automated insulin dose calculations
  3. Understand the FDA's regulatory pathway to the "artificial pancreas" and appreciate the progress made to date.
VIEW PRESENTATION
12:00-1:30 pm     

Pituitary Case Studies (MB) Beverly M.K. Biller, MD, FACP

  1. Review the anatomy and physiology of the pituitary gland.
  2. Be aware of the causes of hyperprolactinemia and the indications for treatment.
  3. Describe a differential diagnosis of sellar masses.

VIEW PRESENTATION

VIEW OUTLINE

1:30-3:00 p.m   

 Hands-On Practicum (HB) Drs. Bode, Hirsch, Grunberger,

  1. Discuss the patient selection process for insulin pump therapy
  2. Appreciate the role of pre-pump education and and need of ongoing patient education about pump features
  3. Demonstrate features of insulin pumps and discuss their clinical application
 
3:00-3:30 p.m.Coffee Break (HBF) 
3:30-5:15 p.m.

Patient Cases – Interactive Problem Solving (HB) Moderator:  George Grunberger, MD, FACP, FACE

Panel:  Dace L. Trence, MD, FACE ,TBD and Rodica Pop-Busui, MD

  1. Learn about the use and limitations of diabetes technology in specific patient cases from real world clinical setting.
 
5:15 p.m Adjourn 
5:30-6:45 p.m. Tech Expo and Wine & Cheese Reception (WB) 

PROGRAM – TUESDAY, March 5, 2019

Rethinking Lipid Management to Reduce CVD: Statin Therapy & Beyond

Moderator:  Vinaya Simha, MD, MBBS

Schedule and Sessions
Time
Event
Supporting Files
7:00-7:30 a.m. Breakfast and Exhibits (HBF) 
7:30-8:00 a.m.

 Lipid Physiology and Pathogenesis of Monogenic Lipid Disorders (HB)

 Vinaya Simha, MD, MBBS

1. Appreciate the role of lipids in multiple physiological processes

2. Understand the basic principles of lipoprotein structure and function

3. Understand the molecular basis of genetic disorders of lipid metabolism and transport

VIEW PRESENTATION
8:00-8:45 a.m  

 Landmark Lipid Trials and Current Lipid Treatment Guidelines (HB) Francisco Lopez-Jiminez, MD

1. Briefly review major primary and secondary prevention trials of statin therapy

2. Review the evidence from non-statin trials to understand the role of combination lipid lowering therapy

3. Understand the basis and limitations of different lipid treatment guidelines

VIEW PRESENTATION
8:45-9:30 a.m  

Residual Risk and Novel Therapies (HB) Vinaya Simha, MD, MBBS

1. Appreciate the magnitude of residual cardiovascular risk after statin therapy

2. Understand the basis for novel and emerging lipid lowering therapies

3. Review evidence for efficacy of novel therapies to understand their role in clinical practice

VIEW PRESENTATION
9:30-9:40 a.m. 

Question and Answer Session (HB) Vinaya Simha, MD, MBBS and Francisco Lopez-Jiminez, MD

 
9:40-10:00 a.m. 

Break and Exhibits (HBF)

Obesity Medicine – An Interactive Session Utilizing the Audience Response System (ARS)

Moderator:  W. Timothy Garvey, MD, FACE

 
10:00-10:25 a.m.

Obesity Pathophysiology and AACE Obesity CPGs (HB)

W. Timothy Garvey, MD, FACE

  1.  Understand medical models of obesity management and rationale for a complications centric approach
  2. Review the evidence demonstrating weight loss as an effective therapeutic tool to treat obesity-related complications
VIEW PRESENTATION
10:25-10:50 a.m.

Lifestyle Management with Diet, Activity/Exercise, and Behavior Support (HB) Meera Shah, MBChB

1.  Understand principles of effective lifestyle intervention as a key role in obesity medicine

2.  Understand the impact of weight loss therapy regarding type-2 diabetes prevention

VIEW PRESENTATION
10:50-11:15a.m.

Medical Management of Obesity (HB)

W. Timothy Garvey, MD, FACE

1.         Become familiar with efficacy, safety, and role of medications in obesity management

2.         Understand the impact of weight loss medical therapy in preventing type-2 diabetes

VIEW PRESENTATION
11:15-11:40 a.m.

Surgical Management of Obesity (HB) Daniel Hurley, MD, FACE

  1. Become familiar with efficacy, safety, and role of bariatric surgery in obesity management
  2. Understand the impact of bariatric weight loss therapy in the treatment of type-2 diabetes
VIEW PRESENTATION
11:40 a.m. – Noon 

Question and Answer Session (HB) W. Timothy Garvey, MD, FACE, Meera Shah, MbChB, Daniel Hurley, MD, FACE

 
12:00pm – 1:00pm  Lunch. 
1:00-2:15 p.m. 

Transgender Health for Endocrinologists:  A Case-Based Approach (HB)

Vin Tangpricha, MD, PhD, FACE and Caroline Davidge-Pitts, MBBCh

  1. Review definitions and terminology in transgender health
  2. Understand the reason and modalities for medical management of transgender people
  3. Review cross hormone therapy and surgical techniques and discuss some challenges in management
VIEW PRESENTATION
2:15-4:30 pmMayo Tours 
3:00 - 4:30 pmBreak and Exhibits 
4:30-5:30 p.m. 

PCOS: Diagnostic Pearls and Management Strategies (HB) Alice Chang, MD

  1. Understand diagnostic criteria and how to individualize test selection
  2. Understand how to screen and treat for co-morbidities of PCOS
  3. Select among treatment options based on patient goals
VIEW PRESENTATION
5:30 p.m.     Adjourn 
6:15pm-8:00pm 

Dinner - Who Wants to be a Millionaire Endocrinologist (MB) No CME for this session - William Young, MD, MSc, FACP, FACE

 

PROGRAM – WEDNESDAY, MARCH 6, 2019

Endocrine Laboratory Testing and Reproductive Technologies

Moderator:  William F. Young, Jr., MD, FACP, FACE

Schedule and Sessions
Time
Event
Supporting Files
6:45-7:30 a.m.  

Breakfast and Exhibits (HBF)

 
7:30-8:30 a.m.

Diagnostic Evaluation of Pheochromocytoma (HB) - William F. Young, Jr., MD, MSc, FACP, FACE 

1. Review the diagnostic approach to the patient with possible pheochromocytoma

2. Demonstrate the various localization studies available to the endocrinologist

3. Discuss the role for genetic testing in the setting of paraganglioma or pheochromocytoma

4. Review follow-up strategies following resection of a pheochromocytoma

VIEW PRESENTATION
8:30-9:30 a.m.

Cutting Edge Reproductive Endocrinology (HB) Jani R. Jensen, MD

  1. Understand basic reproductive endocrinology testing for the evaluation of fertility problems
  2. Discuss types of fertility treatment and their anticipated success rates
  3. Learn about the latest technological advancements for deferring reproduction
VIEW PRESENTATION
9:30-9:45a.m.

Break and Exhibits (HBF)

 
9:45-10:45 a.m.

Lab Secrets: What Endocrinologists Should Know in Interpreting Endocrine Test Results (HB) - Ravinder Singh, PhD

  1.  Review the pathophysiology of Vitamin D endocrine system and apply to case management
  2. Discuss how to use current testosterone assays (total, free, bioavailable)
  3. Apply the limitations of estrogen-related testing to the clinical setting of the postmenopausal woman
VIEW PRESENTATION
10:45 -11:45 a.m.  

Invasive Dynamic Endocrine Testing (HB) William F. Young, Jr., MD, MSc, FACP, FACE 

1. Review the endocrine disorders that may be subjected invasive dynamic endocrine testing.

2. Summarize the key steps in performing and interpreting adrenal venous sampling and inferior petrosal sinus sampling

3. Give examples of how to use invasive dynamic endocrine testing in endocrine practice

VIEW PRESENTATION
11:45am-12:45 p.m.

Product Theater – Lunch (no CME for this session)

Bone Module

Moderator:  Robert A. Wermers, MD FAC

 
1:00-1:30 p.m.  

 Clinical Approach to Metabolic Bone Disease (HB) Robert A. Wermers, MD, FACE

1.      Describe a general clinical approach to metabolic bone diseases

2.     Appreciate causes of high bone mass

3.     Understand causes of low bone mass

VIEW PRESENTATION
1:30-3:00 p.m.

Fracture Risk Assessment Panel Discussion (HB)

Dan L. Hurley, MD, FACE, Moderator

Matthew Drake (Case 1)

Kurt Kennel, MD (Case 2)

Bart Clarke, MD (Case 3)

Matthew Drake (Case 4)

1.     Understand noninvasive measures of bone microarchitecture (Case 1 – TBS, FEA, HRpQCT)

2.     Identify pitfalls of DXA BMD interpretation (Case 2 – DXA BMD and VFA)

3.     Understand proper use of FRAX and its limitations (Case 3 – FRAX)

4.     Review the relationship between diabetes and fracture risk (Case 4 – diabetes related risk of fracture)

 
3:00-3:30 p.m. Coffee Break (HBF) 
3:30-4:00 p.m.   

Fracture Liaison Service (FLS) – What is a FLS and What is the Endocrinologist’s Role in FLS? (HB) Ann Kearns, MD

1.      Know the fundamental components of a FLS

2.     Describe the role of a FLS in quality measures

3.     Identify members of a FLS team, and recognize the endocrinologist’s role within the team

VIEW PRESENTATION
4:00-4:45 p.m. 

Hypercalcemia and Hypocalcemia (HB)

Robert A. Wermers, MD, FACE and Bart Clarke, MD

Objectives:

1.      Understand the causes, evaluation, and pitfalls in hypercalcemic disorders

2.      Know the causes, evaluation, and treatment of hypocalcemia, including hypoparathyroidism

VIEW PRESENTATION

VIEW PRESENTATION

4:45-5:15 p.m. 

Renal Bone Disease and Bone Histomorphometry (HB)

Daniel L. Hurley, MD, FACE and Robert A. Wermers, MD, FACE

1.      Understand the complexities of renal bone disease, including the assessment of bone volume, turnover, and mineralization

2.     Review the limitations of current osteoporosis therapies in the treatment of osteoporosis in chronic kidney disease

3.     Review the indications for bone biopsy in patients with renal bone disease

4.     Recognize the value of bone histomorphometry in the assessment of bone disease in chronic kidney disease

VIEW PRESENTATION

VIEW PRESENTATION

5:15-5:30 p.m.Question and Answer Session (HB) 
5:30 p.m.  Adjourn for Day – Dinner on own 

PROGRAM – THURSDAY, March 7, 2019

The Essentials of Achieving a Successful and Rewarding Practice

Moderator:  Daniel L. Hurley, MD, FACE

Schedule and Sessions
 
Time
Event
Supporting Files
7:00-7:30 a.m.    Breakfast (HBF) 
7:30-9:00 a.m.

  Enhancing Your Communication and Leadership Skills (HB) Daniel L. Hurley, MD, FACE

                                       

  1. Be able to understand principles of effective leadership regardless of practice or organization
  2. Learn about effective communication to help you enhance your ability to communicate with supervisors, employees, colleagues, patients and others in your career.
VIEW PRESENTATION
9:00-9:30 a.m.  Break (HBF) 
9:30-11:30 a.m.

The Business of Medicine (HB) Robert Liles, JD,MS,MBA

Educate young physicians as to the non-clinical aspects of practicing medicine, to include but not limited to:

  • Civil Liability (risk management)
  • Licensure
  • Physician Contract Negotiations
  • Government Sanctions
  • Third Party Payors
  • Asset Protection
  • Market Issues
  • Staffing
VIEW PRESENTATION
11:30 a.m.       Endocrine University® Adjourns 

OTHER RESOURCES

A Method Using Superconcentrated Gelatin and a Novel Phantom Suspension System for Ultrasound-Guided Thyroid Biopsy Training

ARS Sistrunk 2019

Kahler Grand Hotel
Rochester, MN
United States

Faculty

Click/Touch to Expand

 

 

Dev Abraham MD, MRCP (UK), ECNU, FACE

Professor of Medicine (Clinical)

Adjunct Professor of Surgery and Pathology

Assistant Dean of Academic Affairs, School of Medicine,

University of Utah,

Salt Lake City, UT

Beverly MK Biller, MD, FACP
Professor of Medicine

Harvard Medical School

Neuroendocrine Unit, Massachusetts General Hospital

Boston, MA

Bruce W. Bode, MD, FACE

Atlanta Diabetes Associates

Associate Professor of Medicine

Emory University School of Medicine

Atlanta, GA

Alice Chang, MD. MSc

Associate Professor

Division of Endocrinology, Metabolism and Nutrition

Mayo Clinic

Rochester, MN

Bart Clarke, MD, FACP, FACE

Professor of Medicine,

Mayo Clinic College of Medicine

Rochester, MN

Caroline Davidge-Pitts, MBBCH

Internist, Endocrinologist
Endocrinology, Diabetes, Metabolism and Nutrition

Mayo Clinic
 Rochester, MN

Diana Dean, MD, FACE

Associate Professor of Medicine

Mayo Clinic of Medicine

Rochester, MN

Matthew Drake, MD

Mayo Clinic College of Medicine

Rochester, MN

James Garrity, MD

Professor of Ophthalmology

Mayo Clinic of Medicine

Rochester, MN

W. Timothy Garvey, MD. FACE

Professor and Chair, Department of Nutrition Sciences

University of Alabama at Birmingham

Director, UAB Diabetes Research Center
Birmingham, AL

 

Hossein Gharib, MD, MACP, MACE

Dean, Endocrine University®

Professor of Medicine

Mayo Clinic College of Medicine

Rochester, MN

George Grunberger, MD, FACP, FACE

Chairman, Grunberger Diabetes Institute

Clinical Professor, Internal Medicine and Molecular Medicine & Genetics

Wayne State University School of Medicine

Professor, Internal Medicine

Oakland University Beaumont School of Medicine

Visiting Professor, First Faculty of Medicine, Charles University, Prague

Detroit, MI

R. Mack Harrell, MD, FACP, FACE, ECNU
President – American College of Endocrinology
Co-Director Memorial Center for Integrative Endocrine Surgery

Hollywood, Pembroke Pines, Weston and Boca Raton, Florida

Irl B. Hirsch, MD

Professor of Medicine

University of Washington School of Medicine

Seattle, WA

Mimi Hu, MD

Associate Professor

Department of Endocrine Neoplasia and Hormonal Disorders

University of Texas M. D. Anderson Cancer Center
 Houston, TX

Mimi Hu, MD

Associate Professor

Department of Endocrine Neoplasia and Hormonal Disorders

University of Texas M. D. Anderson Cancer Center
 Houston, TX

Daniel L. Hurley, MD, FACE

President Elect, American Association of Clinical Endocrinologists –

Assistant Professor of Medicine

Mayo Clinic College of Medicine

Rochester, MN

Jani Jensen, MD

Reproductive Medicine and Infertility Associates
 Edina, MN

Ann E Kearns, MD, PhD

Associate Professor of Medicine

Mayo Clinic College of Medicine

Rochester, MN

Kurt A. Kennel, MD

Assistant Professor of Medicine

Program Director, Endocrinology Fellowship Program

Division of Endocrinology, Metabolism and Nutrition

Mayo Clinic College of Medicine
Rochester, MN

Robert A. Levine, MD, FACE, ECNU

Thyroid Center of New Hampshire
Saint Joseph Hospital Endocrinology

Adjunct Assistant Professor of Medicine

Geisel School of Medicine - Dartmouth College

Nashua, NH

Robert Liles

Liles Parker

Washington DC

Francisco Lopez-Jiminez, MD
Professor of Medicine

Mayo College of Medicine

Chair, Division of Preventive Cardiology

Department of Cardiovascular Medicine

Rochester, Minnesota

Mark A. Lupo, MD, FACE, ECNU

Assistant Clinical Professor

Florida State University College of Medicine

Thyroid & Endocrine Center of Florida

Sarasota, FL

Debra Margulies, MD, FACE, ECNU
Summit Medical Group

New Jersey Chapter of AACE, Board of Directors

Morristown, NJ

 

Mira Milas, MD

Professor of Endocrine surgery

University of AZ

Phoenix, AZ

 

Richard Pratley, MD

Transitional Research Institute for Metabolism and Diabetes

Orlando, FL

Michael Rivera, MD
Assistant Professor

Department of Pathology

Mayo Clinic

Rochester, MN

Susan Samson, MD

Associate Professor of Medicine

Baylor College of Medicine

Houston, TX

Meera Shah

Mayo Clinic College of Medicine

Rochester, MN

Vinaya Simha

Mayo Clinic College of Medicine

Rochester, MN

Ravinder Singh, MD
Professor and Clinical Mass Spectrometry Laboratory Director

Department of Laboratory Medicine and Pathology

Mayo Clinic

Rochester, MN

J. Woody Sistrunk, MD, FACE, ECNU

Jackson Thyroid and Endocrine Clinic, PLLC

Jackson, MS

Marius N. Stan, MD, MSc

Assistant Professor of Medicine

Mayo Clinic College of Medicine

Rochester, MN

Dace Trence, MD, FACE
Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition

Director, Endocrine Fellowship Program

Director, Diabetes Care Center

University of Washington

Seattle, WA

Vin Tangpricha, MD, PhD, FACE
Professor of Medicine

Department of Endocrinology, Metabolism and Lipids

Emory University School of Medicine

Atlanta, GA

Robert A. Wermers, MD, FACE

Associate Professor of Medicine

Mayo Clinic College of Medicine

Rochester, MN

William F. Young, Jr., MD, MSc, FACP, FACE

Professor of Medicine

Mayo Medical School

Mayo Clinic

Rochester, MN

 

 

AACE/ACE Principles of Endocrine Neck Sonography Course ™

Ultrasound Lab Sonographers

 

Dawn Boynton, RDMS, RVT

Byron, MN

Jana Hansen, RDMS, RVT

Mankato, MN

Jackie Kaddatz, BS, RDMS

Carmel, NY

Crystal Koski, RDMS, RVT

Hayfield, MN

Becky Madery, RDMS

Rochester, MN

Kevin Rooker, RT(R), RDMS, RVT

Poolville, TX

 

Kate Ryan, RDMS, RVT

Oronoco, MN

Emily Smith, BS, RDMS, RVT

Rochester, MN

Michelle Waletzko, RDMS, RVT

Kasson, MN

Sara Willaert ARDMS, RVT

Mankato, MN

Joel Wolery, RDMS

Rochester MN

Irina Bancos, MD

Assistant Professor of Medicine

Mayo Clinic College of Medicine

Rochester, MN

 

Karen B. Grothe, PhD, LP
Assistant Professor of Psychology

Mayo Clinic college of Medicine

Rochester MN

 

*Jan L Kasperbauer, MD

Associate Professor of Anatomy

Professor of Otolaryngology

Mayo Clinic College of Medicine

Rochester, MN

* Yogish C. Kudva, MBBS

Mayo Clinic College of Medicine
Rochester, MN

*Travis J McKenzie, MD

Associate Professor of Surgery,

Mayo Clinic College of Medicine

Rochester, MN

 

Todd Nippoldt, MD
Associate Professor of Medicine

Mayo Clinic School of Medicine

Rochester, MN

 

Melanie L. Richards, MD

Professor of Surgery

Mayo Clinic College of Medicine

Rochester, MN

Robert Rizza, MD

Professor of Medicine

Endocrinology, Diabetes, Metabolism and Nutrition

Mayo Clinic College of Medicine

Rochester, MN

*Thom W. Rooke, MD, FSVM

Mayo Clinic College of Medicine
Rochester, MN

*Meera Shah, MD, ChB

Mayo Clinic College of Medicine
Rochester, MN

Peter Tebben, MD
Adult and Pediatric Endocrinology

Mayo Clinic

Rochester, MN

 

*Geoffrey B. Thompson, MD

Professor of Surgery

Mayo Clinic College of Medicine

Rochester, MN

*Adrian Vella, MD

Professor of Medicine,

Mayo Clinic College of Medicine

Rochester, MN

* Faculty  for non CME session(s)  only

Disclosures

Faculty Disclosures
Bart Clarke
  1. Allergan
  2. Bristol Myers Squibb
  3. Takeda
  1. Consulting Fees
  2. Consulting Fees
  3. Research Grant
Bruce Bode
  1. Abbott
  2. Aseko
  3. AstraZeneca
  4. Becton Dickinson
  5. Boehringer Ingelheim
  6. DexCom
  7. Diasome
  8. Eli Lilly
  9. Insulet
  10. MannKind
  11. Medtronic
  12. Novo Nordisk
  13. Sanofi
  14. Senseonics 
  1. Research Grant
  2. Research Grant
  3. Honorarium, Research Grant
  4. Research Grant
  5. Honorarium, Research Grant
  6. Research Grant
  7. Research Grant
  8. Research Grant
  9. Research Grant
  10. Honorarium, Research Grant
  11. Honorarium, Research Grant
  12. Honorarium, Consulting Fees, Research Grant
  13. Honorarium, Research Grant
  14. Honorarium, Research Grant
Dace Trence
  1. Medtronic
  2. Sanofi-Aventis
  1. Stockholder
  2. Stockholder
George Grunberger       1. Medtronic       1. Contract Research
Irl Hirsch
  1. Abbott Diabetes Care
  2. Becton Dickinson
  3. BigFoot
  4. Medtronic Diabetes
  5. Roche
  1. Consulting Fees
  2. Consulting Fees
  3. Consulting Fees
  4. Grant/Research Support
  5. Consulting Fees
Jani Jensen       1. Ferring       1. Consulting Fees
Mimi Hu
  1. Blueprint Medicines
  2. Loxo Oncology
  1. Consulting Fees, Contracted Research
  2. Consulting Fees, Contracted Research
Richard Pratley
  1. AstraZeneca
  2. Eli Lilly
  3. GlaxoSmithKline
  4. Janssen
  5. Lexicon
  6. Ligand Pharmaceuticals, Inc.
  7. Merck
  8. Mundipharma
  9. Novo Nordisk
  10. Sanofi 
  1. Consulting Fees
  2. Consulting Fees, Grant/ Research Support
  3. Consulting Fees
  4. Consulting Fees, Grant/ Research Support
  5. Grant/Research Support
  6. Consulting Fees, Grant/ Research Support
  7. Consulting Fees, Grant/ Research Support
  8. Consulting Fees
  9. Honorarium, Consulting Fees, Research Grant
  10. Consulting Fees, Grant/ Research Support
Robert Wermers      1. Alexion Pharmaceuticals, Inc1.  Research Grant
Rodica Pop-Busui
  1. AstraZeneca
  2. Novo Nordisk
  1. Research Grant
  2. Consulting Fees
W. Timothy Garvey
  1. Sanofi
  2. Novo Nordisk
  3. Merck
  4. Pfizer
  5. Gilead
  6. Amgen
  7. BOYDSense
  1. Contracted Research
  2. Contracted Research, Consultant
  3. Contracted Research
  4. Contracted Research
  5. Consultant
  6. Consultant
  7. Consultant
Sonographers Disclosures
Emily Smith
  1. CIVCO Medical Solutions
  2. Veracyte
  1. Salary
  2. Consulting Fees
Kevin Rooker       1.CIVCO Medical Solutions       1. Salary

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 43.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

This course meets 15 CME credits for AACE ECNU Program Initial certification. 

Available Credit

  • 43.50 AMA
  • 43.50 Attendance

Accreditation Period

Course opens: 
02/28/2019
Course expires: 
12/31/2019

Price

Cost:
$0.00
Please login or register to take this course.